Pentwater Capital Management LP Seagen Inc. Transaction History

Pentwater Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $623 Million - $703 Million	3,250,500 Added 33.76%	12,880,000 $2.73 Billion
Q2 2023 Aug 14, 2023	BUY	$187.64 - $206.25 $1.48 Billion - $1.62 Billion	7,874,500 Added 448.69%	9,629,500 $1.85 Billion
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $224 Million - $356 Million	1,755,000 New	1,755,000 $355 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Pentwater Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Pentwater Capital Management LP with notifications on news.